Susquehanna International Group, LLP Horizon Therapeutics Public LTD CO Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $18.3 Million - $21.4 Million	-185,200 Reduced 15.78%	988,800 $114 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $58.1 Million - $67.8 Million	603,300 Added 105.71%	1,174,000 $121 Million
Q1 2023 May 16, 2023	SELL	$107.32 - $113.5 $46.7 Million - $49.4 Million	-435,000 Reduced 43.25%	570,700 $62.3 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $57.5 Million - $105 Million	921,400 Added 1093.0%	1,005,700 $114 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $453,684 - $651,959	-7,700 Reduced 8.37%	84,300 $5.22 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.